COVID-19 CLINICAL TRIAL RESEARCH STUDY

ENROLLING PATIENT VOLUNTEERS NOW!

Eligible Participants Who Complete the Study Receive $3400 in Compensation
NOLA Research Works is conducting clinical trial research for a promising antibody medication designed to treat COVID-19. Developed by pharmaceutical giant, Eli Lilly, the antibody medicine has shown a 72-percent risk reduction of hospitalization in patients with mild to moderate symptoms of the virus.

FREE COVID-19 RAPID TEST FOR PATIENTS WHO MEET OUR CRITERIA

Free testing is available to potential clinical trial patient volunteers who meet the following criteria:

1. At Least 2 Symptoms of COVID-19
   Symptoms of COVID-19 include, but may not be limited to patients who are currently experiencing: Fever, cough, sore throat, achy/not feeling well, headache, muscle pain, digestive issues, and shortness of breath when active
2. Underlying Medical Conditions
   Underlying medical conditions include, but may not be limited to: Obesity, kidney disease, diabetes, immunosuppression, cardiovascular disease, hypertension, and COPD
3. Meaningful Interest in Participating in Our Study, If Test Results are Positive
   The Eli Lilly BLAZE-1 Study is designed to test how effective the antibody medicine LY-CoV555 is as a treatment for COVID-19. LY-CoV555 is an antibody from a blood sample taken from one of the first patients who recovered from COVID-19, and is specifically designed to neutralize the virus. The study will last approximately 12 weeks, including 1 required visit at the study site and the remainder in-home or by phone. Patient volunteers who complete the study will receive $3400 compensation.

Benefits to participation in our study include: 1. Antibody medicine proven to treat the COVID-19 virus, 2. Quality, comprehensive health care provided by a team of MD’s, RN’s, and research professionals, 3. Contribution to help find a cure, and 4. $3400 compensation to patient volunteers who complete the study.

Important Note: The correlation between testing eligibility and a patients’ health condition is fluid, and a direct reflection of the requirements of our Eli Lilly clinical trial research study at the time a patient may need to be tested for COVID-19. While an interested patient who has 2 or more symptoms and underlying medical conditions is a standard of our study, Eli Lilly often includes patients who don’t have underlying conditions. The best way to determine your eligibility for receiving a Free COVID-19 Rapid Test is to complete the Register Now form on this web page.

REGISTER TO DETERMINE YOUR ELIGIBILITY FOR OUR FREE RAPID TEST

Free COVID-19 Rapid Testing through NOLA Research Works is directly tied to our clinical trial research study and is only available to patients who meet Eli Lilly’s criteria. Patients who schedule a test are subject to evaluation by a healthcare provider to confirm symptoms, and if applicable, underlying conditions, prior to testing. If a patient does not meet the requirements, the patient may not be granted testing access.

For questions, please call 504-534-3111.